Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 46708-767

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 46708-767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Paroxetine 25 mg)

Paroxetine Extended-Release Tablets, USP 25 mg film-coated tablets in a carton label from Alembic Pharmaceuticals Limited. The label states each extended-release tablet contains paroxetine hydrochloride equivalent to 25 mg paroxetine and includes storage instructions and dispensing information. The package contains 30 tablets.*

FDA Label Image

30 Tablets (Paroxetine 37 5 mg)

Label for Paroxetine Extended-Release Tablets, USP 37.5 mg by Alembic Pharmaceuticals Limited. The label indicates 30 tablets per package and includes storage instructions, dispensing notes, and a barcode. The packaging specifies prescription use only and lists manufacturer details from Gujarat, India.*

FDA Label Image

Paroxetine-fig1.jpg (Paroxetine Fig1)

A graph showing fold change and 90% confidence intervals of drug interaction pharmacokinetics for paroxetine with several drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg). The chart plots Cmax and AUC values relative to reference, on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Paroxetine-fig2.jpg (Paroxetine Fig2)

A chart depicting the pharmacokinetic (PK) fold change and 90% confidence interval (CI) in Cmax and AUC for Paroxetine when administered with various interacting drugs: Cimetidine 300 mg three times daily, Phenobarbital 100 mg once daily, Phenytoin 300 mg once daily, Digoxin 0.25 mg once daily, and Diazepam 5 mg three times daily. The graph indicates the relative changes compared to reference values.*

FDA Label Image

Paroxetine-fig3.jpg (Paroxetine Fig3)

A pharmacokinetic fold change chart displaying Cmax, AUC, and Cmin values with 90% confidence intervals for paroxetine in various populations including those with mild, moderate, and severe renal impairment, hepatic impairment, age over 65 at different doses, and by gender (males). The x-axis shows change relative to reference on a logarithmic scale from 0.5 to 50.*

FDA Label Image

Paroxetine-str.jpg (Paroxetine Str)

Chemical structure diagram of paroxetine hydrochloride, showing a fluorophenyl group, oxygen-containing ring, and piperidine ring with associated hydrogen chloride (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.